# Revenue Cycle Management Automation Market — research notes
**Slug:** revenue-cycle-management-market   **Drafted:** 2026-10-16   **Renamed to the published slug:** 2026-10-18

> **Published as `revenue-cycle-management-market`, not as
> `revenue-cycle-management-automation-market`.** The report's own finding is
> that no defensible standalone size for RCM *automation* exists, so it
> publishes whole-market RCM with automation as the growth vector — and a title
> promising an automation market size while the headline figure is the whole
> market would have been the same defect in the title bar. The original draft is
> kept at `content/reports/_superseded-revenue-cycle-management-automation-market.json`.


## Published estimates (what others say)

| Source | Published | Base year | Base value | Forecast year | Forecast value | CAGR | Scope as stated |
|---|---|---|---|---|---|---|---|
| MarketsandMarkets | 2025 edition | 2025 | **$65.49B** | 2030 | $117.50B | 12.4% (2024–2030) | Revenue cycle management, global. Scope **stated**: offerings split front-end, mid-cycle and back-end products **plus outsourcing services**, with a separate **AI versus non-AI technology segmentation**; AI-based solutions described as the fastest-growing technology segment. Also publishes $58.27B for 2024 |
| Towards Healthcare | last updated 21 April 2026 | 2024 | $20.68B | 2034 | $180.33B | 24.20% | **"AI in healthcare revenue cycle management"** — scope **stated**: *"the use of artificial intelligence to automate and improve billing, coding, claims processing, and payment tasks."* Segmented by component (software, services), type (integrated AI-RCM platforms, standalone AI-RCM tools), deployment, application (claims and denials management, eligibility and benefits verification), end user. Also publishes $25.7B for 2025. The page gives the CAGR period inconsistently (overview says 2024–2034, metrics table says 2025–2034) |
| Allied Market Research | 2022 edition | 2021 | $109.53B | 2031 | $367.7B | 13.2% (2022–2031) | Revenue cycle management, global |
| Global Market Insights | April 2023 edition | 2022 | $141.2B | 2032 | $489.2B | 12.8% (2023–2032) | **Healthcare** revenue cycle management, global |
| Grand View Research | 2023 release | — | — | 2030 | **$658.7B** | 11.39% (2024–2030) | Revenue cycle management, global. Reached us only through a third-party repost; **not verified against Grand View's own page** |
| Fortune-style syndicated report (via GII) | — | 2024 | $156.68B | 2031 | $343.12B | 11.8% | Also publishes segment rates: solutions component 10.5% CAGR, outsourcing services 12.5% CAGR |
| Precedence Research | — | — | — | 2027 | $135.12B | 12.5% (2022–2027) | Revenue cycle management, global |
| Arizton (not comparable) | 2025 edition | 2024 | $141.61B | 2030 | $272.78B | 11.55% | **United States only.** Recorded because its US-only base of $141.61B exceeds MarketsandMarkets' entire **global** market of $65.49B for the following year — a 2.2x contradiction between two houses on an identical geography-inclusive basis |
| Ken Research | — | — | — | 2030 | ~$201B | ~11% | Revenue cycle management, global |
| DataM Intelligence | — | — | — | 2033 | ~$291B | — | Revenue cycle management, global |

## The spread

- **Base-year values, 2024 or 2025: $58.27B (MarketsandMarkets, 2024) to
  $156.68B (the GII-syndicated report, 2024) — a 2.69x spread.** Adding
  Arizton's **US-only** $141.61B for 2024 makes the picture worse rather than
  better, because a US-only figure 2.4x a global figure for the same year cannot
  both be right.
- **2030 forecast values: $117.50B (MarketsandMarkets) to $658.7B (Grand View) —
  a 5.6x spread.**
- **Published CAGRs for whole-market RCM: 11.39% to 13.2% — a 1.16x spread.**

As usual, the growth rate is the stable part of the literature and the level is
not. But this market has a second, more serious problem that the others in this
batch do not: **nobody credible sizes RCM automation separately.**

MarketsandMarkets carries an AI-versus-non-AI technology segmentation inside its
whole-market report but does not publish the split. The only automation-specific
estimate we found is Towards Healthcare's "AI in healthcare revenue cycle
management" at $20.68B for 2024 growing at 24.20%, and the grounding arithmetic
below shows that figure cannot be vendor revenue.

The scope decision behind the 5.6x gap is the familiar one in services markets:
whether you count **what vendors are paid** or **what the function costs**.
Providers run most of their revenue cycle with their own staff. A house that
counts the internal cost of billing departments, or the value of claims
processed, lands in the hundreds of billions. A house that counts vendor
software licences and outsourcing contracts lands in the tens.

## Grounding arithmetic

Three independent denominators are available, and they agree with each other.

**Denominator 1 — total US administrative cost of healthcare.** National health
expenditures reached **$5.3 trillion in 2024** (CMS NHE, released January 2026),
with hospital care at **$1,634.7 billion** and physician and clinical services
at **$1,109.7 billion**. The Peterson-KFF Health System Tracker puts
administrative expenses at **7.0% of total national health expenditures in
2024**, down from 7.5% in 2023 and a peak of 8.4% in 2020.

```
7.0% × $5,278.6B (Health Affairs' 2024 NHE total) = $369.5B
```

That $369.5 billion is **everything administrative in US healthcare** — payer
overhead, government programme administration, underwriting margin and provider
billing operations combined.

### Test 1 — the high estimates against the whole administrative cost base

```
$658.7B (Grand View Research, global RCM by 2030)
/ $369.5B (all US healthcare administration, 2024)
= 1.78x
```

A global RCM market 1.78 times the entire US administrative cost base is
arithmetically possible only if the rest of the world's health systems spend
multiples of what the United States does on administration — and the United
States is the acknowledged global outlier in administrative intensity. **It is
not a coherent figure.** The same applies to GMI's $489.2B for 2032 and Allied's
$367.7B for 2031, both of which approach or match the whole US administrative
base.

### Test 2 — the whole-market estimate against provider billings

```
$73.61B (MarketsandMarkets, advanced to 2026)
/ $2,744.4B (US hospital care + physician and clinical services, 2024)
= 2.68%
```

Again a global numerator over a US-only denominator, so an upper bound. Spending
under 3% of billed provider revenue on revenue cycle software and outsourcing
combined is **below** the 4–8% of collections that RCM outsourcing contracts
typically carry, which is consistent with most providers still running the
function in-house. This figure is plausible.

### Test 3 — the automation estimate against the vendors who sell automation

Waystar is the largest listed pure-play revenue cycle software company. Its
fiscal 2025 results (reported 17 February 2026) show **total revenue of $1,099
million**, up 17% year on year and 13% organically, split **$558.4 million
subscription** and **$534.8 million volume-based**, with 2026 guidance of
$1.274–$1.294 billion. R1 RCM, the largest outsourcer, guided fiscal 2024
revenue to **$2.625–$2.675 billion** before being taken private; it no longer
reports. Ensemble Health Partners is private and discloses nothing — the only
public figure we could find for it is a commercial database's unaudited
"$100–500 million" range, which is a statistical estimate and not usable.

```
$31.90B (Towards Healthcare's AI-in-RCM market, advanced to 2026)
/ $1.099B (Waystar's entire FY2025 revenue, all products, AI or not)
= 29.0x
```

**The published AI-in-RCM market is 29 times the total revenue of the largest
pure-play RCM software company — counting all of that company's revenue, not
just its automation.** Adding R1's last reported ~$2.65 billion, the two largest
visible participants together are under $4 billion. A $31.9 billion automation
market would require roughly eight more R1s and twenty more Waystars that nobody
has heard of.

### What the three tests together establish

The honest bracket is narrow at the top and the bottom. A whole-market figure
must be large enough to accommodate R1 and Waystar and the outsourcing industry
behind them, and small enough that it does not exceed the entire administrative
cost of the world's most administratively expensive health system.
MarketsandMarkets' series sits inside that bracket. The hundreds-of-billions
series do not, and the automation-specific series does not.

**These are plausibility tests, not market estimates.**

## What we publish

**Headline:** $73.61B (2026) → $148.44B (2032) at 12.4%.

Source: MarketsandMarkets, which publishes $58.27B for 2024, $65.49B for 2025
and $117.50B for 2030 at a stated 12.4% CAGR. Those endpoints are internally
consistent ($65.49B → $117.50B over five years implies 12.40% exactly). The 2026
base is the published 2025 value advanced one year at that rate
($65.49B × 1.124 = $73.61B) and the 2032 endpoint continues it
($73.61B × 1.124⁶ = $148.44B). Both are interpolation on a published rate, not
separately published observations, and are labelled as such.

Chosen because it is the only house that **states an AI-versus-non-AI technology
segmentation** inside a stated scope that names front-end, mid-cycle and
back-end products plus outsourcing services, it is internally arithmetically
consistent, and it is the only series that survives all three grounding tests.

**We publish this as whole-market RCM with automation as the growth vector, and
we say on the page that no defensible standalone size for RCM automation
exists.** That is the finding. Publishing $31.9 billion for AI-in-RCM when the
largest vendor in the category bills $1.1 billion would be the opposite of
useful.

Unit: USD Billion. Industry: Healthcare IT.

## Do not publish

- **Vendor market share.** Waystar's $1,099M FY2025 revenue divided by any
  published market gives a number, but Waystar's scope and each house's scope do
  not match, R1 and Ensemble no longer report, and the outsourcing half of the
  market is dominated by private firms. The arithmetic belongs in prose with both
  numbers named. `competitive_landscape[].market_share` omitted.
- **A standalone market size for RCM automation.** The only one published fails
  the vendor-revenue test by 29x. Recorded in the spread table, explained, not
  used as a headline.
- **Regional splits.** Arizton's US-only series contradicts the global series it
  would have to sit inside. `regional_analysis` stays `[]`.
- **Country splits.** `country_analysis` stays `[]`.
- **The Grand View $658.7B figure as a verified estimate.** It reached us only
  through a third-party repost and we could not confirm it on Grand View's own
  page. Recorded as the high bound with that caveat.
- **A wiuwi.com figure of 45.80% CAGR** found in search results. Its own
  endpoints ($308B 2023 → $751.7B 2032) imply roughly 10%. Discarded as
  internally incoherent; recorded here only so the next pass does not pick it up.
- **An Ensemble Health Partners revenue figure.** The only number available is a
  commercial database's unaudited $100–500M range, which that database itself
  describes as a statistical evaluation.
- **A derived percentage of provider collections spent on RCM.** The 2.68% above
  is a deliberately mismatched global/US ratio used as an upper bound and is
  labelled as such everywhere it appears.
- **The exact 2024 "government administration" dollar line from the NHE
  accounts.** We could not read it: the CMS NHE highlights PDF would not extract,
  and the only figure we found ($66.1 billion for 2024) came from a Health
  Affairs *projections* paper rather than the final historical tables. We use the
  Peterson-KFF 7.0%-of-NHE administrative share instead and say so.

## Sources

1. Centers for Medicare & Medicaid Services, National Health Expenditure Fact Sheet (2024 data, released January 2026): NHE $5.3 trillion in 2024, up 7.2%, $15,474 per person, 18.0% of GDP; hospital care $1,634.7 billion; physician and clinical services $1,109.7 billion — https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet
2. Peterson-KFF Health System Tracker, "How has U.S. spending on healthcare changed over time?": administrative expenses 7.0% of total national health expenditures in 2024, down from 7.5% in 2023 and a peak of 8.4% in 2020 — https://www.healthsystemtracker.org/chart-collection/u-s-spending-healthcare-changed-time/
3. Health Affairs, "National Health Care Spending Increased 7.2 Percent In 2024 As Utilization Remained Elevated" (2024 NHE $5,278.6 billion; Medicaid government administration costs rose 19.8% in 2024 against 9.2% in 2023, attributed to continued Medicaid unwinding operations) — https://www.healthaffairs.org/doi/10.1377/hlthaff.2025.01683
4. American Hospital Association, Fast Facts on U.S. Hospitals, 2024 AHA Annual Survey: 6,100 hospitals; 5,121 community hospitals; 907,216 staffed beds; 35,658,583 admissions — https://www.aha.org/statistics/fast-facts-us-hospitals
5. Waystar Holding Corp., "Waystar Reports Fourth Quarter and Fiscal Year 2025 Results, Provides 2026 Guidance", 17 February 2026 (FY2025 revenue $1,099M, up 17% and 13% organic; subscription $558.4M up 22%; volume-based $534.8M up 11%; Q4 revenue $304M up 24% with 12% organic; 2026 guidance $1.274–$1.294 billion) — https://investors.waystar.com/news-releases/news-release-details/waystar-reports-fourth-quarter-and-fiscal-year-2025-results
6. TipRanks / The Fly, "R1 RCM sees FY24 revenue $2.625B–$2.675B" (also FY2024 GAAP operating income $105–135 million and adjusted EBITDA $650–670 million) — https://www.tipranks.com/news/the-fly/r1-rcm-sees-fy24-revenue-2-625b-2-675b-consensus-2-69b — **guidance, not a final reported figure; R1 was taken private and no longer reports**
7. MarketsandMarkets, revenue cycle management market, report 153900104 ($58.27B 2024; $65.49B 2025; $117.50B 2030; 12.4% CAGR 2024–2030; front-end/mid-cycle/back-end products plus outsourcing services; separate AI vs non-AI technology segmentation) — https://marketsandmarkets.com/Market-Reports/revenue-cycle-management-market-153900104.html
8. Towards Healthcare, AI in healthcare revenue cycle management market sizing, last updated 21 April 2026 ($20.68B 2024; $25.7B 2025; $180.33B 2034; 24.20% CAGR; scope and segmentation as quoted) — https://www.towardshealthcare.com/insights/ai-in-healthcare-revenue-cycle-management-market-sizing
9. Allied Market Research, revenue cycle management market ($109.53B 2021 → $367.7B 2031, 13.2% CAGR 2022–2031) — https://www.alliedmarketresearch.com/press-release/revenue-cycle-management-market.html
10. Global Market Insights, healthcare revenue cycle management market, April 2023 edition ($141.2B 2022 → $489.2B 2032, 12.8% CAGR 2023–2032) — https://www.gminsights.com/industry-analysis/healthcare-revenue-cycle-management-market
11. Grand View Research, revenue cycle management market ($658.7B by 2030, 11.39% CAGR 2024–2030) — cited via https://www.outsourcestrategies.com/blog/healthcare-revenue-cycle-management-market-to-reach-usd-489-billion-by-2032/ and other reposts — **third-party summary, not the primary release**
12. Precedence Research, "Revenue Cycle Management Market Size Gain USD 135.12 BN by 2027" ($135.12B by 2027, 12.5% CAGR 2022–2027) — https://www.biospace.com/revenue-cycle-management-market-size-gain-usd-135-12-bn-by-2027
13. Arizton, "U.S. Revenue Cycle Management Market — Focused Insights 2025-2030" ($141.61B 2024 → $272.78B 2030, 11.55% CAGR; **United States only**) — https://www.arizton.com/market-reports/us-revenue-cycle-management-market
14. GII-syndicated revenue cycle management report ($156.68B 2024 → $343.12B 2031 at 11.8%; solutions component 10.5% CAGR, outsourcing services 12.5% CAGR) — https://m.giikorea.co.kr/report/go1559749-revenue-cycle-management.html
15. Becker's Hospital Review, "8 Ensemble partnerships in 2024" (Ensemble named best company for end-to-end revenue cycle outsourcing in 2024 by KLAS Research) — https://www.beckershospitalreview.com/finance/3-ensemble-partnerships-in-2024/
16. CMS, "Summary of the 2024 Comprehensive Revision to the National Health Expenditure Accounts" (renamed "Net Cost of Health Insurance" to "Health Insurance Non-Medical Ratio", still representing administrative costs, taxes, fees and underwriting gains and losses as a share of total private health insurance expenditures) — https://www.cms.gov/files/document/summary-benchmark-changes-2024.pdf
